SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is trending as its fervent community rallies behind the "OG meme" narrative, positioning Rage Comics as a foundational "meme reset" for the crypto market. Enthusiasts demonstrate strong conviction by actively developing an ecosystem with platforms like RageMaker and RageGames, rallying others to "Return to the Memes" and "Rage On" to assert dominance.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is trending with gold prices hitting record highs, fueled by intense safe-haven demand amidst growing concerns over dollar weakness, global debt, and geopolitical tensions. The community is sharply divided, with bulls pointing to de-dollarization and massive short covering, while bears warn of a speculative bubble and an imminent pullback.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending amidst a disputed Reuters report suggesting the U.S. is moving away from guaranteed price floors for critical minerals, which the community largely views as a market manipulation "hit piece." Many investors are buying the dip, asserting that CRML's robust heavy rare earth project and pre-sold concentrate make it less reliant on such policies, while eagerly anticipating an upcoming critical minerals summit.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trending as investors anticipate its earnings report, a recently announced $5 billion share repurchase program, and a significant new AI partnership with OpenAI. The community is sharply divided, with some lamenting what they perceive as irrational "manipulation" and a broader "anti-SaaS" sentiment, while others are bullish on the company's strong fundamentals and AI-driven growth strategy.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is trending after its earnings report showed beats on top and bottom lines, but the stock is falling due to investor concerns over slowing Azure cloud growth, substantial capital expenditures for AI, and pressured margins, leading the community to question the immediate return on its aggressive AI investments including OpenAI.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is actively discussed following its latest earnings report, which highlighted a strategic shift away from Model S and X production towards an aggressive ramp-up in Optimus robots and robotaxis, sparking both fervent bullish excitement for its AI-driven future and strong bearish concern over unproven ventures and increasing capital expenditures.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

A widely contested report about the U.S. government potentially ending critical mineral price floors is driving a sector-wide sell-off for United States Antimony Corp, yet the community largely dismisses this as market manipulation and views the ensuing dip as a buying opportunity. Bullish sentiment is further fueled by UAMY's unique role as a domestic antimony producer for defense, recent processing advancements, and a significant production halt at a major Chinese antimony plant.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the Materials and Magnetics segments. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials experienced a significant dip following a Reuters report suggesting the U.S. government would cease minimum price guarantees for critical minerals; however, the company quickly refuted the claim, asserting its long-term price protection agreement with the Department of Defense is fully intact, leading many in the community to view this as a manipulation and MP as a uniquely positioned leader in the sector.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is trending as newly green-lit data center projects in Southeast Asia significantly expand its pipeline and revenue outlook, fueling community discussions around a potential re-rating and notable institutional buying. Enthusiasm is also high for upcoming corporate updates expected to further clarify its rapidly growing AI and cybersecurity ventures.

Fefe is a memecoin inspired by Matt Furie's book "Mindviscosity," published in 2020.  Follow FEFE, the alter ego of PEPE in the book “Mindviscosity” by Matt Furie.  Fefe is a main character in the book, who is a laid back and carefree frog living in a whimsical world. Fefe's relaxed and adventurous spirit captures the heart of this imaginative universe.  Launched stealth with no presale, zero taxes, LP burnt and contract renounced - TAX: 0/0 This narrative has its roots in a fascinating story.  Join us and become part of the $FEFE community today!

Fefe

FEFE Crypto is trending as its passionate community champions its unique narrative as the literal representation of Pepe's 4Chan experience by creator Matt Furie. Positioned as the next "Shiba Inu to Pepe" and a massively undervalued micro-cap within the frog coin meta, enthusiasts are discussing its significant growth potential as a truly community-owned asset.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Acumen Pharmaceuticals (NASDAQ:ABOS) Price Target Raised to $7.00 at BTIG Research

BTIG Research boosted their price objective on shares of Acumen Pharmaceuticals from $4.00 to $7.00 and gave the company a "buy" rating in a research note on Tuesday...

Acumen Pharmaceuticals (NASDAQ:ABOS) CFO Sells $12,536.16 in Stock

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS - Get Free Report) CFO Matt Zuga sold 6,888 shares of the stock in a transaction dated Thursday, January 8th. The shares were sold at an average price of...

Insider Selling: Acumen Pharmaceuticals (NASDAQ:ABOS) CFO Sells 6,888 Shares of Stock

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS - Get Free Report) CFO Matt Zuga sold 6,888 shares of Acumen Pharmaceuticals stock in a transaction dated Thursday, January 8th. The shares were sold at an...

Acumen Pharmaceuticals (NASDAQ:ABOS) CEO Sells $14,820.26 in Stock

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS - Get Free Report) CEO Daniel Joseph Oconnell sold 8,143 shares of the stock in a transaction on Thursday, January 8th. The shares were sold at an average...

Acumen Pharmaceuticals (NASDAQ:ABOS) CEO Daniel Joseph Oconnell Sells 12,941 Shares

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS - Get Free Report) CEO Daniel Joseph Oconnell sold 12,941 shares of the business's stock in a transaction that occurred on Friday, January 9th. The stock was...

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Receives Average Rating of "Moderate Buy" from Brokerages

Shares of Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS - Get Free Report) have earned an average rating of "Moderate Buy" from the five research firms that are presently covering the company...

James Doherty Sells 6,467 Shares of Acumen Pharmaceuticals (NASDAQ:ABOS) Stock

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS - Get Free Report) insider James Doherty sold 6,467 shares of the company's stock in a transaction on Thursday, January 8th. The stock was sold at an average...

Acumen Pharmaceuticals (NASDAQ:ABOS) CFO Matt Zuga Sells 5,100 Shares

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS - Get Free Report) CFO Matt Zuga sold 5,100 shares of the business's stock in a transaction dated Tuesday, January 6th. The stock was sold at an average...

Acumen Pharmaceuticals (NASDAQ:ABOS) Upgraded at Wall Street Zen

Wall Street Zen upgraded Acumen Pharmaceuticals from a "sell" rating to a "hold" rating in a research note on Sunday...

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Receives Average Recommendation of "Moderate Buy" from Analysts

Shares of Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the five research firms that are currently covering the company...

Acumen Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages and develops medicines and diagnostics for Alzheimer's disease. The company was founded by William L. Klein, Grant A. Krafft, and Caleb Finch in 1996 and is headquartered in Newton, MA.

ABOS
Acumen Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ABOS News

ABOSAcumen Pharmaceuticals Inc